Literature DB >> 10853442

Effects of endothelin-1 and calcium channel blockers on contractions in human myometrium. A study on myometrial strips from normal and diabetic pregnant women.

T Kaya1, A Cetin, M Cetin, Y Sarioglu.   

Abstract

OBJECTIVE: We studied the effect of endothelin (ET)-1 on spontaneous contractions and the effects of nimodipine and isradipine on ET-1-induced contractions in myometrial tissue from normal and diabetic pregnant women. STUDY
DESIGN: We isolated myometrial strips from seven normal pregnant and seven gestational diabetic women undergoing elective cesarean section at term. Three sets of experimental studies were performed with three myometrial strips obtained from every woman and mounted in organ baths for recording of isometric tension. In the first set, the effect of increasing concentrations of ET-1 (10(-11)-10(-8) M) on spontaneous contractions was recorded. In the second and third sets, effects of increasing concentration of nimodipine (10(-6)-3.10(-5) M) and isradipine (10(-5)-3.10(-4) M), respectively, on contractions following pretreatment with 10(-8) M ET-1 were recorded.
RESULTS: ET-1, beginning from 10(-9) M and 10(-10) M, significantly increased the amplitude of contractions in normal and diabetic strips, respectively. ET-1, beginning from 10(-9) M, also increased the frequency of contractions in normal and diabetic strips. The amplitude of contractions was significantly higher in diabetic strips as compared with normal strips at 10(-9) and 10(-8) M. There was no significant difference in the frequency of contractions between normal and diabetic strips. ET-1 at 10(-8) M also increased the basal tone of all normal and diabetic strips. Nimodipine, beginning from 10(-6) M and 3.10(-6) M, and isradipine, beginning from 10(-5) M and 3.10(-5) M, significantly decreased the amplitude of contractions in normal and diabetic strips, respectively. Nimodipine at 10(-5) M and 3.10(-5) M and isradipine at 3.10(-4) M significantly decreased the frequency of contractions in normal strips. Nimodipine, except at 3.10(-5) M, and isradipine did not significantly decrease the frequency of contractions in diabetic strips.
CONCLUSION: Gestational diabetes increases ET-1-induced contractile response in human myometrium. The contractile effect of ET-1 in normal and diabetic myometrium is mediated partly by dihydropyridine-sensitive calcium channels since it is significantly reduced by nimodipine and isradipine. The promising data from this study warrant clinical studies on the definitive place of nimodipine and isradipine in the treatment of preterm labor, especially in a diabetic woman, to avoid metabolic complications of beta-mimetic tocolytics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10853442

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

1.  Effects of long-term diabetes on the structure and cell proliferation of the myometrium in the early pregnancy of mice.

Authors:  Rodolfo R Favaro; Renato M Salgado; Priscila R Raspantini; Zuleica B Fortes; Telma M T Zorn
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

2.  Prevention of inflammation-associated preterm birth by knockdown of the endothelin-1-matrix metalloproteinase-1 pathway.

Authors:  Wei Wang; Haoting Yen; Chih-Hung Chen; Nitesh Jasani; Rimabahen Soni; Karen Koscica; Sandra E Reznik
Journal:  Mol Med       Date:  2010-08-18       Impact factor: 6.354

3.  The endothelin-converting enzyme-1/endothelin-1 pathway plays a critical role in inflammation-associated premature delivery in a mouse model.

Authors:  Wei Wang; Haoting Yen; Hauting Yen; Chih-Hung Chen; Rimabahen Soni; Nitesh Jasani; Georges Sylvestre; Sandra E Reznik
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

4.  Influence of high glucose in the expression of miRNAs and IGF1R signaling pathway in human myometrial explants.

Authors:  Udo R Markert; Telma M T Zorn; Rodolfo R Favaro; Diana M Morales-Prieto; Jörg Herrmann; Jürgen Sonnemann; Ekkehard Schleussner
Journal:  Arch Gynecol Obstet       Date:  2021-02-11       Impact factor: 2.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.